Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Cadila Healthcare

Sector: Healthcare | Industry: Drugs & Pharma
R 247.85 2.60  | 1.06% -34.34% 14.99 25,368.34
NSE Price: Oct 23, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:59 247.85 2.60 1.06% 246.00 245.25 626,600 243.25 - 249.00
BSE Oct 23, 2019 247.80 2.70 1.10% 245.50 245.10 17,732 243.30 - 248.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue13,768.2013,165.6011,954.509,376.509,426.80 8,651.307,224.00
Other Income122.40206.20113.30147.10116.60 57.2058.00
Total Income13,890.6013,371.8012,067.809,523.609,543.40 8,708.507,282.00
Total Expenditure10,808.1010,197.609,125.907,475.007,097.30 6,897.406,031.20
Operating Profit3,082.503,174.202,941.902,048.602,446.10 1,811.101,250.80
Interest247.60193.5091.1063.1052.80 67.9090.20
PBDT2,834.902,980.702,850.801,985.502,393.30 1,743.201,160.60
Depreciation628.40598.60538.80373.30292.10 287.30201.20
PBT & Exceptional Items2,206.502,382.102,312.001,612.202,101.20 1,455.90959.40
Exceptional Items0.00---0.30-2.50 -10.40-17.20
Profit before Tax2,206.502,382.102,312.001,611.902,098.70 1,445.50942.20
Provision for Tax489.10530.30564.40128.90177.40 259.40106.00
Profit after Tax1,717.401,851.801,747.601,483.001,921.30 1,186.10836.20
Minority Interest-64.90-49.90-34.60-29.10-30.40 -37.60-32.60
Share of Associate39.4046.9062.8033.8043.00 --
Consolidated Profit1,691.901,848.801,775.801,487.701,933.90 1,150.60803.60
 
LiabilitiesR Cr
Share Capital102.40102.40102.40102.40102.40 102.40102.40
Total Reserves10,283.9010,283.908,642.106,857.605,596.80 4,149.203,336.60
Shareholder's Funds10,386.3010,386.308,744.506,960.005,699.20 4,251.603,439.00
Minority Interest1,292.901,292.90191.00156.10135.80 168.90144.30
Long Term Borrowings3,949.703,949.702,555.102,468.40896.40 1,150.401,362.20
Other Non Current Liabilities511.70259.40209.60214.00157.30 191.10227.00
Current Liabilities7,342.507,342.506,083.005,305.803,461.00 3,285.102,814.00
Total Debt*-7,899.405,406.705,207.202,442.00 2,651.302,700.40
Total Liabilities23,483.1023,230.8017,783.2015,104.3010,349.70 9,047.107,986.50
 
AssetsR Cr
Net Block6,874.7012,163.706,482.605,755.103,747.90 3,352.203,123.80
Non Current Investments443.60443.60470.90385.70217.10 33.2022.20
Other Non-Current Assets7,666.702,125.402,600.002,941.202,104.30 1,435.001,402.60
Current Investments229.90229.90274.8049.10199.10 121.2064.40
Cash and Bank649.30649.301,314.901,543.50638.70 669.90548.80
Other Current Assets7,618.907,618.906,640.004,429.703,442.60 3,435.602,824.70
Net Current Assets1,155.601,155.602,146.70716.50819.40 941.60623.90
Miscellaneous Exp. Not Written Off----- --
Total Assets23,483.1023,230.8017,783.2015,104.3010,349.70 9,047.107,986.50
 
Cash FlowR Cr
From Operations-2,882.30919.301,311.701,893.50 993.60902.80
From Investing Activities--5,738.70-973.70-2,871.90-863.50 -464.70-438.00
From Finance Activities-1,884.6051.502,315.80-934.80 -351.10-528.70
Net Inflow/Outflow--971.80-2.90755.6095.20 177.80-63.90
 
Key Ratios
Adjusted EPS (Rs)16.5318.0517.3414.5318.89 11.227.85
Adjusted Book Value (Rs)104.53101.4385.4067.9755.66 41.5233.58
Dividend per Share (Rs)-3.503.503.203.20 2.401.80
Cash Flow per Share (Rs)-28.158.9812.8118.49 48.5244.08
Debt to Equity0.380.760.620.750.43 0.620.79
Current Ratio1.161.161.351.141.24 1.291.22
ROCE (%)-15.8818.2616.5028.60 23.2117.20
RONW (%)17.9519.3622.2623.4338.62 30.8526.20
Operating Margin (%)22.3924.1124.6121.8525.95 20.9317.31
Net Margin (%)12.3613.8514.4815.5720.13 13.6211.48
Revenue Growth (%)9.1610.1327.49-0.538.96 19.7613.63
Net Profit Growth (%)-17.855.9617.84-22.8161.98 41.8421.21
EPS Growth (%)-19.374.1119.37-23.0768.38 42.9222.97
Book Value Growth (%)-18.7825.6422.1234.05 23.6316.79
 
Market Cues
Close Price (Rs)247.85347.05377.85442.00316.90 348.36204.99
High Price (Rs)380.90432.50560.00460.75453.30 352.76215.94
Low Price (Rs)206.50305.95362.00304.20295.00 174.42125.80
Market Cap (Rs Cr)25,368.3435,491.8438,773.7645,388.8032,455.68 35,620.8621,020.67
Price / Earnings14.9919.2021.8330.5116.78 31.0226.16
Price / Book Value2.373.424.436.525.69 8.386.11
Dividend Yield (%)1.411.010.920.721.01 0.690.88
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
2.94
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
14.99
5-Years Price to Book
2.37
Earnings Yield
EBIT / Enterprise value
7.58%
PEG
Price / Earnings to growth ratio
1.05
Related Stocks
  Current Price   Chng %
Abbott India R10,914.25 +2.00%
Alkem Laboratories R1,966.85 -0.40%
Biocon R258.30 +0.53%
Cipla R454.25 +0.08%
Glaxosmithkline Pharma R1,488.55 +0.50%
Lupin R736.15 -1.30%
Pfizer R3,270.65 +0.32%
Piramal Enterprises R1,720.75 +2.40%
Sanofi India R6,120.70 +0.14%
Torrent Pharmaceuticals R1,680.25 +0.61%
As on Oct 23, 15:59